ethamsylate has been researched along with Prostatic Hyperplasia in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (18.75) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 8 (50.00) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dahm, P; Gandhi, S; Hwang, EC; Imamura, M; Jung, JH; Kim, MH; Pang, R | 1 |
| Egawa, S; Endo, K; Furuta, A; Naruoka, T; Sugaya, S; Suzuki, Y | 1 |
| Hayashi, T; Hiura, M; Ikeda, H; Kanaoka, T; Nakano, T; Nakashima, M; Nishiyama, R; Ogawa, O; Tamaki, M | 1 |
| Egawa, S; Hatano, T; Ikemoto, I; Kagami, Y; Kira, S; Mizuo, T; Nakajo, H; Tomita, M | 1 |
| Kyotani, J; Oka, M; Oyama, T; Tanaka, M; Ueda, M | 1 |
| Hanai, T; Matsui, T; Matsumoto, S; Oka, M; Tanaka, M; Uemura, H | 1 |
| Kakehi, Y; Oka, M; Sugimoto, M; Tsunemori, H; Yamashita, M | 1 |
| Okada, H | 1 |
| Kamai, T; Sakakibara, R; Tsujii, T; Uchiyama, T; Yamanishi, T; Yasuda, K; Yoshida, K | 1 |
| Kaplan, SA | 1 |
| Hong, BF; Li, NC; Ma, LL; Na, YQ; Song, Y; Wan, B; Wang, XF | 1 |
| Hashimoto, T; Hayami, S; Ishigooka, M; Mitobe, K; Nakada, T; Tomaru, M | 1 |
| Blandy, JP; Lyttle, JA; Offen, DN; Symes, DM | 1 |
| Booth, CM; Lyth, DR | 1 |
| Kaneko, S; Kurita, T; Matsuura, T; Wakabayashi, A | 1 |
| Hiramatsu, M; Koda, A; Yoshida, Y | 1 |
2 review(s) available for ethamsylate and Prostatic Hyperplasia
| Article | Year |
|---|---|
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Benzilates; Drug Combinations; Ethamsylate; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Plant Extracts; Prostatic Hyperplasia; Prostatism; Quality of Life; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Urological Agents | 2018 |
[BPH pharmacotherapy (miscellaneous)].
Topics: Alanine; Drug Combinations; Ethamsylate; Glutamates; Glycine; Humans; Male; Plant Extracts; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Secale; Treatment Outcome | 2002 |
8 trial(s) available for ethamsylate and Prostatic Hyperplasia
| Article | Year |
|---|---|
[Assessment of clinical usefulness of Eviprostat for benign prostatic hyperplasia--comparison of Eviprostat tablet with a formulation containing two-times more active ingredients].
Topics: Aged; Drug Combinations; Ethamsylate; Humans; Male; Middle Aged; Plant Extracts; Prostatic Hyperplasia; Tablets | 2008 |
[One-week effects of Tamsulosin on benign prostatic hyperplasia assessed with a daily symptom score].
Topics: Adrenergic alpha-Antagonists; Aged; Drug Combinations; Ethamsylate; Humans; Male; Medical Records; Plant Extracts; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Urinary Retention | 2009 |
Eviprostat suppresses urinary oxidative stress in a rabbit model of partial bladder outlet obstruction and in patients with benign prostatic hyperplasia.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antioxidants; Deoxyguanosine; Drug Combinations; Ethamsylate; Humans; Male; Middle Aged; Oxidative Stress; Phytotherapy; Plant Extracts; Prostatic Hyperplasia; Rabbits; Urinary Bladder Neck Obstruction | 2010 |
Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Aged; Drug Combinations; Ethamsylate; Humans; Male; Naphthalenes; Phytotherapy; Piperazines; Plant Extracts; Plant Preparations; Prostatic Hyperplasia; Single-Blind Method; Urodynamics | 2004 |
Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Bias; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Ethamsylate; Humans; Male; Muscle Hypertonia; Naphthalenes; Phytotherapy; Piperazines; Plant Extracts; Prostatic Hyperplasia; Single-Blind Method; Treatment Outcome; Urinary Bladder Neck Obstruction; Urodynamics | 2005 |
Clinical and retrospective evaluation of Eviprostat: a non-hormonal and non-neuropharmacological agent for benign prostatic hyperplasia.
Topics: Aged; Aged, 80 and over; Drug Combinations; Ethamsylate; Humans; Male; Middle Aged; Plant Extracts; Prostate; Prostatectomy; Prostatic Hyperplasia; Retrospective Studies | 1995 |
The effect of dicynene on blood loss during and after transurethral resection of the prostate.
Topics: Aged; Benzenesulfonates; Blood Pressure; Clinical Trials as Topic; Ethamsylate; Hemorrhage; Hemostatics; Humans; Male; Organ Size; Placebos; Postoperative Complications; Prostate; Prostatectomy; Prostatic Hyperplasia; Thrombophlebitis | 1975 |
Does ethamsylate reduce haemorrhage in transurethral prostatectomy?
Topics: Aged; Aged, 80 and over; Blood Loss, Surgical; Double-Blind Method; Ethamsylate; Hemorrhage; Humans; Male; Middle Aged; Postoperative Complications; Prostatectomy; Prostatic Hyperplasia | 1990 |
6 other study(ies) available for ethamsylate and Prostatic Hyperplasia
| Article | Year |
|---|---|
[Evaluation of supplemental administration of Eviprostat in patients with benign prostatic hyperplasia with persistent symptoms following treatment with alpha1-adrenoceptor blocker].
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Drug Combinations; Ethamsylate; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Plant Extracts; Prostatic Hyperplasia; Quality of Life | 2008 |
Effect of the phytotherapeutic agent Eviprostat on 17beta-estradiol-induced nonbacterial inflammation in the rat prostate.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Disease Models, Animal; Drug Combinations; Estradiol; Ethamsylate; Male; Orchiectomy; Organ Size; Oxidative Stress; Phytotherapy; Plant Extracts; Prostate; Prostatic Hyperplasia; Prostatitis; Rats; Rats, Wistar | 2009 |
Effect of a phytotherapeutic agent, Eviprostat®, on prostatic and urinary cytokines/chemokines in a rat model of nonbacterial prostatitis.
Topics: Animals; Chemokines; Cytokines; Drug Combinations; Ethamsylate; Male; Phytotherapy; Plant Extracts; Prostate; Prostatic Hyperplasia; Prostatitis; Rats; Rats, Wistar | 2011 |
[Clinical study of Eviprostat for the treatment of benign prostatic hyperplasia].
Topics: Aged; Aged, 80 and over; Drug Combinations; Ethamsylate; Humans; Male; Middle Aged; Plant Extracts; Prostatic Hyperplasia; Quality of Life; Treatment Outcome; Urodynamics | 2005 |
[Conservative treatment of benign prostatic hypertrophy: reevaluation of the effect of eviprostat by subjective symptoms and uroflowmetry].
Topics: Aged; Benzenesulfonates; Drug Combinations; Drug Evaluation; Ethamsylate; Humans; Male; Middle Aged; Plant Extracts; Prostatic Hyperplasia; Urine; Urodynamics | 1986 |
[Pharmacological study of prostate extracts. (IV). Prostatic acid phosphotases from several different species, and the effect of prostate extracts on these enzymes].
Topics: Acid Phosphatase; Adrenal Glands; Animals; Cysteine; Drug Combinations; Ethamsylate; Ethanol; Formaldehyde; Haplorhini; Humans; Kidney; Liver; Lung; Male; Plant Extracts; Pollen; Prostate; Prostatic Hyperplasia; Rats; Seminal Vesicles; Species Specificity; Spleen; Tartrates; Testis; Thioglycolates; Thymus Gland; Tissue Extracts | 1974 |